BridgeMD
New treatment option for Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Official title Multimodal Prehabilitation Program That Combines Physical Exercise, Psychological Intervention and Nutritional Support to Improve the Response to Neoadjuvant Chemoterhapy in Early Breast Cancer Patients
ClinicalTrials.gov ID: NCT07107594
What this study is testing
- What it's testing
- The aim of this clinical trial is to evaluate whether following a multimodal prehabilitation program including physical exercise, nutritional support and psychological intervention during neoadjuvant chemotherapy in breast cancer patients could improve the pathological response to chemotherapy. 214 women with non-metastatic breast cancer with indication of chemotherapy before surgery will be eligible to participate.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Histologically confirmed diagnosis of non-metastatic breast cancer: stages cT1-T4, cN0-N3, M0, and candidates for neoadjuvant chemotherapy (NAC).
- Age ≥ 18 years.
- Signed informed consent.
You likely can't join if
- Contraindication or physical inability to perform moderate-to-high intensity physical exercise.
- Pregnant or breastfeeding patients.
- Presence of other active synchronous neoplasms.
- Metastatic breast cancer (stage IV).
- Patients already engaging in regular physical exercise: more than 150 minutes of moderate or intense aerobic exercise per week.
- Male breast cancer patients.
See the full eligibility criteria
- Histologically confirmed diagnosis of non-metastatic breast cancer: stages cT1-T4, cN0-N3, M0, and candidates for neoadjuvant chemotherapy (NAC).
- Age ≥ 18 years.
- Signed informed consent.
- Contraindication or physical inability to perform moderate-to-high intensity physical exercise.
- Pregnant or breastfeeding patients.
- Presence of other active synchronous neoplasms.
- Metastatic breast cancer (stage IV).
- Patients already engaging in regular physical exercise: more than 150 minutes of moderate or intense aerobic exercise per week.
- Male breast cancer patients.
- Personal history of a previous malignancy treated with chemotherapy.
- Severe or poorly controlled psychiatric illness (including uncontrolled active substance abuse).
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.